Clinical trial
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
NCT00005918 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00005918 |
|---|---|
| Title | Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients |
| Official title | The Safety and Antiviral Efficacy of Stavudine Extended Release Formulation as Compared to Stavudine Immediate Release Formulation, Each as Part of Potent Antiretroviral Combination Therapy |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Efavirenz, Lamivudine, Stavudine |
| Enrollment | 730 |
| Start date | Jun 1, 2000 |
| Primary completion | Apr 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | Aug 31, 2001 |
| Last update posted | May 4, 2011 |
| Countries | Argentina, Australia, Belgium, Brazil, Canada, France, Israel, Italy, Mexico, Portugal, Puerto Rico, Russia and 4 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: